Drug profile · INN
fitusiran sodium
QFITLIA
fitusiran sodium (QFITLIA) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
Drug details — fitusiran sodium
- US status
- approved
- Class
- —
- Route
- SUBCUTANEOUS
- Patents
- 2
- Programs
- 3
- Data quality
- 0.84
Quick answer
fitusiran sodium (QFITLIA) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related patents
Frequently asked questions
What is fitusiran sodium?
fitusiran sodium (QFITLIA) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for fitusiran sodium?
QFITLIA is a marketed brand name for fitusiran sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of fitusiran sodium?
fitusiran sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.